Key Statistics
About Atai Beckley N.V
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
Analyst Ratings
View All →| Date | Firm | Rating |
|---|---|---|
| Oct 22, 2025 | Canaccord Genuity | |
| Oct 13, 2025 | Needham | |
| Sep 23, 2025 | HC Wainwright & Co. |